Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha adrenoceptors--an overview.

M J Davey

    Journal of Molecular and Cellular Cardiology
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Noradrenaline release is controlled by alpha-adrenoceptors, which differ in structure and signaling. Enhanced alpha 1-adrenoceptor activity in the heart contributes to arrhythmias, but antagonists show promise for treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prediction of obstructive sleep apnoea in children and adolescents with Down syndrome.

    Journal of intellectual disability research : JIDR·2023
    Same author

    Can actigraphy measure sleep fragmentation in children?

    Archives of disease in childhood·2009
    Same author

    Investigation of sleep disorders.

    Journal of paediatrics and child health·2005
    Same author

    Accuracy of emergency department bedside ultrasonography.

    Emergency medicine (Fremantle, W.A.)·2001
    Same author

    Mechanisms of DNA replication.

    Current opinion in chemical biology·2000
    Same author

    Emergency department ultrasound scanning for abdominal aortic aneurysm: accessible, accurate, and advantageous.

    Annals of emergency medicine·2000
    Same journal

    Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.

    Journal of molecular and cellular cardiology·2026
    Same journal

    SnRNA-seq identifies FN1-SDC4 axis triggering epicardial activation in right ventricular remodeling in pulmonary hypertension.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Therapeutic impact of normal dietary patterns on diabetic cardiomyopathy: Transcriptomic and proteomic insights.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathy.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Precision modification of heart failure signaling by CRISPR-Cas9 base editing.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Retraction notice to 'Sam68 impedes the recovery of arterial injury by augmenting inflammatory response' [Journal of Molecular and Cellular Cardiology 137 (2019) 82-92].

    Journal of molecular and cellular cardiology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Physiology
    • Neuroscience

    Background:

    • Noradrenaline release is modulated by pre-junctional alpha-adrenoceptors.
    • Alpha-adrenoceptors are classified into alpha 1 and alpha 2 subtypes with distinct structures and signaling pathways.
    • Autoregulation of noradrenaline release by alpha-adrenoceptors ensures tissue concentration homogeneity.

    Purpose of the Study:

    • To investigate the role of alpha 1-adrenoceptors in cardiac arrhythmias.
    • To explore the therapeutic potential of alpha 1-adrenoceptor antagonists in treating catecholamine-induced arrhythmias during myocardial ischemia and reperfusion.

    Main Methods:

    • Characterization of pre- and post-junctional alpha-adrenoceptor effects using agonists and antagonists.
    • Investigation of signal transduction mechanisms for alpha-adrenoceptor subtypes.

    Related Experiment Videos

  • Experimental induction of arrhythmias and assessment of treatment with alpha 1-adrenoceptor antagonists.

    • Main Results:

    • Evidence supports the presence of post-junctional alpha 1-adrenoceptors in the mammalian heart.
    • Enhanced alpha 1-adrenoceptor responsiveness is implicated in catecholamine-induced malignant dysrhythmias during ischemia-reperfusion.
    • Alpha 1-adrenoceptor antagonists effectively restored sinus rhythm in experimental models.

    Conclusions:

    • Loss of noradrenaline autoregulation may lead to transmitter inhomogeneity and arrhythmogenesis.
    • Alpha 1-adrenoceptor antagonists demonstrate significant antiarrhythmic potential.
    • Further research is needed to translate these findings to human clinical applications.